Skip to main content
Premium Trial:

Request an Annual Quote

Transgenomic To Provide Mitochondrial DNA Analysis for Arup Labs

NEW YORK (GenomeWeb News) - Transgenomic will analyze mitochondrial DNA mutations for Salt Lake City-based Arup Laboratories, Transgenomic said yesterday. 
 
Transgenomic's services include analysis of the whole mitochondrial genome and tools to detect mutations.
 
Arup vice president Noriko Kusukawa said mitochondrial diseases are difficult to diagnose, and that they affect around one in 8,500 individuals in the US.
 
Transgenomic president and CEO Craig Tuttle said the agreement will give a "critical diagnostic service to hundreds of patients with mitochondrial disorders."
 
Financial terms of the agreement were not released.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.